The aim of this study was to investigate the development and progression of phenotypic resistance to the HIV-1-reverse transcriptase (RT) inhibitor lamivudine, and genotypic variations of HIV-1-RT occurring under lamivudine treatment in HIV-1-infected human primary monocytes-macrophages (M/M).
Aquaro, S., Svicher, V., CECCHERINI SILBERSTEIN, F., Cenci, A., Marcuccilli, F., Giannella, S., et al. (2005). Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 55(6), 872-878 [10.1093/jac/dki104].
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages
AQUARO, STEFANO;SVICHER, VALENTINA;CECCHERINI SILBERSTEIN, FRANCESCA;CALIO', RAFFAELE;PERNO, CARLO FEDERICO
2005-06-01
Abstract
The aim of this study was to investigate the development and progression of phenotypic resistance to the HIV-1-reverse transcriptase (RT) inhibitor lamivudine, and genotypic variations of HIV-1-RT occurring under lamivudine treatment in HIV-1-infected human primary monocytes-macrophages (M/M).File in questo prodotto:
Non ci sono file associati a questo prodotto.
Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons
